Cargando…
Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathway
Radiation therapy is often combined with androgen deprivation therapy in the treatment of aggressive localized prostate cancer. However, castration-resistant disease may not respond to testosterone deprivation approaches. Enzalutamide is a second-generation anti-androgen with high affinity and activ...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443157/ https://www.ncbi.nlm.nih.gov/pubmed/30933998 http://dx.doi.org/10.1371/journal.pone.0214670 |